Inositol — Research Evidence
The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.
Inositol, particularly myo-inositol (MI) and D-chiro-inositol (DCI), has accumulated a meaningful body of human research across several health areas, with the strongest evidence concentrated in polycystic ovary syndrome (PCOS), gestational diabetes prevention, thyroid health, and fertility. Multiple meta-analyses and systematic reviews are available, lending more credibility to findings in these areas than is typical for dietary supplements. Overall, the evidence suggests genuine biological activity — particularly around insulin signaling and hormonal regulation — though important questions about optimal dosing, long-term outcomes, and specific populations remain open.
The most consistently supported application is PCOS management, where multiple meta-analyses and systematic reviews point to benefits in metabolic and hormonal markers. Myo-inositol at doses of approximately 2–4 grams per day, sometimes combined with D-chiro-inositol in a 40:1 ratio, appears to improve insulin sensitivity and menstrual regularity in affected women. Two meta-analyses also support the use of inositol supplementation during pregnancy to reduce the risk of gestational diabetes mellitus, a clinically meaningful outcome. For thyroid health, particularly subclinical hypothyroidism and Hashimoto's thyroiditis, systematic reviews and network meta-analyses suggest inositol may offer modest benefit, though findings are less definitive. Evidence for fertility support (including IVF outcomes and age-related ovarian decline) is supported by meta-analyses but remains preliminary. In psychiatric conditions such as bipolar disorder, the evidence base is weak and no large well-powered RCTs exist to draw firm conclusions.
Several important caveats apply across this body of evidence. Many studies suffer from small sample sizes, short durations, and heterogeneous populations, limiting generalizability. The expert consensus classification rated 74 out of 96 specific claims as having insufficient evidence, with only one claim fully supported and 21 partially supported — underscoring that much of what is commonly said about inositol outpaces the science. The 40:1 MI:DCI dosing ratio for PCOS, while widely cited, is based on physiological rationale and early data rather than definitive dose-comparison trials. For psychiatric and fertility applications especially, the evidence is too preliminary to support strong clinical recommendations.
Key findings
- ✓Multiple meta-analyses support myo-inositol (typically 2–4 g/day) for improving metabolic and hormonal parameters in women with PCOS, representing the strongest evidence base for this supplement.
- ✓Two meta-analyses of randomized controlled trials indicate that myo-inositol supplementation during pregnancy may reduce the incidence of gestational diabetes mellitus.
- ✓Systematic reviews and network meta-analyses suggest inositol may provide modest benefit in Hashimoto's thyroiditis and subclinical hypothyroidism, though evidence is less definitive.
- ✓Meta-analyses suggest potential fertility benefits (e.g., in women with ovarian aging or undergoing IVF), but study quality and sample sizes limit firm conclusions.
- ✓Evidence for inositol in psychiatric conditions such as bipolar disorder is limited to small or low-quality studies; no large, well-powered RCTs exist in this area.
Evidence gaps
- ?Long-term safety and efficacy data are lacking across most indications — most trials are short-duration and do not establish whether benefits persist or whether adverse effects emerge with extended use.
- ?The optimal dose, form (myo-inositol vs. D-chiro-inositol vs. combined), and ratio for specific conditions have not been established through rigorous head-to-head dose-comparison trials.
- ?Evidence in psychiatric populations is particularly underdeveloped, with no large randomized controlled trials available to confirm or refute signals from smaller studies.
Safety summary
Inositol is generally considered well-tolerated at commonly studied doses, with gastrointestinal symptoms (nausea, bloating) being the most frequently reported side effects. Formal safety data from long-term or high-dose studies are limited, so caution is warranted outside well-studied populations such as women with PCOS or at risk for gestational diabetes.
Studies (20)
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.
Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.
Antioxidants for female subfertility.
Antioxidants for female subfertility.
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
Nutrition and bipolar disorder: a systematic review.
Nutrition and bipolar disorder: a systematic review.
Effects of different supplements on Hashimoto's thyroiditis: a systematic review and network meta-analysis.
Effects of different supplements on Hashimoto's thyroiditis: a systematic review and network meta-analysis.
Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials.
Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials.
Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity.
Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity.
D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
Nutritional supplements and IVF: an evidence-based approach.
Nutritional supplements and IVF: an evidence-based approach.
Inositols: From Established Knowledge to Novel Approaches.
Inositols: From Established Knowledge to Novel Approaches.
Dietary supplements for polycystic ovary syndrome.
Dietary supplements for polycystic ovary syndrome.
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management.
The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management.
Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management.
Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management.
Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes.
Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes.
Ovarian Stimulation Protocol in IVF: An Up-to-Date Review of the Literature.
Ovarian Stimulation Protocol in IVF: An Up-to-Date Review of the Literature.